Clinical trial
Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia
NCT00423943 · University of California, Los Angeles, Other · Completed
Key facts
| NCT number | NCT00423943 |
|---|---|
| Title | Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia |
| Official title | Modafinil for Treatment of Cognitive Dysfunction in Schizophrenia |
| Lead sponsor | University of California, Los Angeles, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder |
| Intervention type | Drug |
| Interventions | modafinil, Placebos |
| Enrollment | 33 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Jan 18, 2007 |
| Last update posted | Sep 29, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: